Tag: Prolactin
Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia
by Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro Sato, MD, PhD; and Kazue Besho, Phc Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu […]
Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain
by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada Kasaraneni, MBBS; Christiane S. Hampe, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is Chief of Psychiatry, Behavioral Health Services, McDonald Army Health Center, Fort Eustis, Virginia; Dr. Acharya is Professor of Obstetrics and Gynecology, UiT-The Arctic University of Norway, Consultant Obstetrician and Gynecologist, University […]
A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report
by Gail T. Arcari, MEd; Asante K. Mendes, MD; and Robert B. Sothern, PhD Ms. Arcari is from Cromwell, Connecticut; Dr. Mendes is from Tufts University School of Medicine, Boston, Massachussetts, and University of Connecticut Health Center, Farmington, Connecticut; and Dr. Sothern is Research Assistant Professor, College of Biological Sciences, University of Minnesota, St. Paul, […]
Baseline Serum Prolactin in Drug-naive, First-episode Schizophrenia and Outcome at Five Years: Is it a Predictive Factor?
by Amresh Shrivastava; Megan Johnston; Yves Bureau; and Nilesh Shah Dr. Shrivastava is Executive Director of the Mental Health Foundation of India (PRERANA Charitable Trust, Mumbai, India) and currently from the Department of Psychiatry at the University of Western Ontario and Lawson Health Research Centre, London, Ontario, Canada; Ms. Johnston is from the University […]
